FDA to consider RSV vaccine for adults in their 50s

By Becker's Hospital Review | Healthcare News & Analysis in Becker's Hospital Review, Channels, Featured, ROOT, Static
February 6, 2024

Respiratory syncytial virus vaccinations could soon extend to adults aged 50-59.

Read the full post on Becker's Hospital Review | Healthcare News & Analysis

Becker's Hospital Review | Healthcare News & Analysis